ESC Premium Access

Discussant review - ATTR-ACT.

Topic: Neurologic Disorders and Heart Disease

Congress Presentation

About the speaker

Professor Jacob George

Kaplan Medical Center, Rehovot (Israel)
2 presentations
0 follower

19 more presentations in this session

Opening question - ATTR-ACT Trial.


ATTR-ACT Trial - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

Speaker: Professor C. Rapezzi (Ferrara, IT)


Questions from the audience and discussion.


Concluding question - ATTR-ACT Trial.


Opening question - COMMANDER HF.


Access the full session

Hot Line Session 3

Speakers: Professor J. George, Professor C. Rapezzi

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Related content

Open Access

SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.

29 August 2021

Open Access

GUIDE-HF - Panel discussion.

27 August 2021

Open Access

GUIDE-HF - Discussant review.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk